Do potential patients prefer tissue plasminogen activator (TPA) over streptokinase (SK)? An evaluation of the risks and benefits of TPA from the patient's perspective. [electronic resource]
Producer: 20001023Description: 888-94 p. digitalISSN:- 0895-4356
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.